{
    "nctId": "NCT05099562",
    "briefTitle": "Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer",
    "officialTitle": "Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 54,
    "primaryOutcomeMeasure": "FACT/GOG-Ntx",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. The patient was at least 18 years old and had reported grade 1 or higher neuropathic symptoms for more than 2 weeks;\n2. Patients were screened for eligibility by the investigator prior to enrollment, including verification of baseline neuropathic symptoms.\n3. Patients had a diagnosis of stage I, II, or IIIA breast cancer;\n4. Have completed at least 2 weeks of chemotherapy;\n5. Higher scores indicate more severe symptoms;\n6. Voluntarily participate in the clinical trial and sign the informed consent form after informed consent (patients voluntarily accept the treatment and give informed consent);\n7. Eastern Cooperative Oncology Group (ECOG ) score of physical condition (0-1);\n8. Patients with previous local recurrence were eligible;\n9. The basic indexes were consistent, and the blood routine and ECG were normal.\n\nExclusion Criteria:\n\n1. patients with needle phobia;\n2. Low platelet count (\\<50 000); co-morbidity with a bleeding disorder; comorbidity with thyroid dysfunction; pregnancy; haemoglobin levels \\<10 g/dl and haematocrit \\<30; anaemia on active pharmacological treatment or receiving blood transfusion or steroids;\n3. having metastatic or recurrent disease, history of preexisting peripheral neuropa- thy prior to chemotherapy, uncontrolled seizure disorder, unstable cardiac disease or myocardial infarction within 6 months prior to study entry;\n4. Being pregnant or nursing, or having used acupuncture for peripheral neuropathy within 6 months prior to study entry;\n5. Life expectancy \\<6 months;\n6. Lymphedema of limbs;",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}